Clinical Trials Browser

Phase 2 × Neoplasms × Dexmedetomidine × Clear all

NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Phase 2 Withdrawn

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable